-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
DMK PHARMACEUTICALS Corp quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2010 to 2022.
- DMK PHARMACEUTICALS Corp Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2023 was -$1.39M, a 68.4% increase year-over-year.
- DMK PHARMACEUTICALS Corp Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2023 was -$22.2M, a 30.4% increase year-over-year.
- DMK PHARMACEUTICALS Corp annual Net Income (Loss) Attributable to Parent for 2022 was -$26.5M, a 42.2% increase from 2021.
- DMK PHARMACEUTICALS Corp annual Net Income (Loss) Attributable to Parent for 2021 was -$45.8M, a 7.21% increase from 2020.
- DMK PHARMACEUTICALS Corp annual Net Income (Loss) Attributable to Parent for 2020 was -$49.4M, a 79.5% decline from 2019.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)